Genethera Stock Market Value
| GTHR Stock | USD 0.0001 0.00 0.00% |
| Symbol | GeneThera |
GeneThera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GeneThera's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GeneThera.
| 09/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in GeneThera on September 29, 2024 and sell it all today you would earn a total of 0.00 from holding GeneThera or generate 0.0% return on investment in GeneThera over 60 days. GeneThera is related to or competes with Rigel Pharmaceuticals, Geron, Verastem, Immutep, and Elevation Oncology. GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of ... More
GeneThera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GeneThera's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GeneThera upside and downside potential and time the market with a certain degree of confidence.
GeneThera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneThera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GeneThera's standard deviation. In reality, there are many statistical measures that can use GeneThera historical prices to predict the future GeneThera's volatility.GeneThera Backtested Returns
We have found three technical indicators for GeneThera, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and GeneThera are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
GeneThera has perfect predictability. Overlapping area represents the amount of predictability between GeneThera time series from 29th of September 2024 to 29th of October 2024 and 29th of October 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GeneThera price movement. The serial correlation of 1.0 indicates that 100.0% of current GeneThera price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
GeneThera lagged returns against current returns
Autocorrelation, which is GeneThera pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GeneThera's pink sheet expected returns. We can calculate the autocorrelation of GeneThera returns to help us make a trade decision. For example, suppose you find that GeneThera has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GeneThera regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GeneThera pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GeneThera pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GeneThera pink sheet over time.
Current vs Lagged Prices |
| Timeline |
GeneThera Lagged Returns
When evaluating GeneThera's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GeneThera pink sheet have on its future price. GeneThera autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GeneThera autocorrelation shows the relationship between GeneThera pink sheet current value and its past values and can show if there is a momentum factor associated with investing in GeneThera.
Regressed Prices |
| Timeline |
Additional Tools for GeneThera Pink Sheet Analysis
When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.